Vunakizumab in Adults with Spondyloarthritis
NCT06770088
·
clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
880
Enrollment
OTHER
Sponsor class
Conditions
Spondyloarthritis (SpA)
Interventions
DRUG:
vnacicizumab
Sponsor
Sun Yat-sen University